Birdwatch Note
2024-01-02 19:50:05 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Effective January 1, 2023, the government set a $35 cap per monthly prescription among Medicare Part D enrollees under the Inflation Reduction Act. The IRA was signed into law on August 16, 2022 by President Biden. Further details available here: https://aspe.hhs.gov/sites/default/files/documents/bd5568fa0e8a59c2225b2e0b93d5ae5b/aspe-insulin-affordibility-datapoint.pdf
Written by 984B1C5559E014CCAD0368AB4C2BBFBA1CFEC8BA0B1E1D8BF5254344F631ADAA
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1741857930587123881
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1742272069394432271
- noteId - 1742272069394432271
- participantId -
- noteAuthorParticipantId - 984B1C5559E014CCAD0368AB4C2BBFBA1CFEC8BA0B1E1D8BF5254344F631ADAA Participant Details
- createdAtMillis - 1704225005852
- tweetId - 1741857930587123881
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Effective January 1, 2023, the government set a $35 cap per monthly prescription among Medicare Part D enrollees under the Inflation Reduction Act. The IRA was signed into law on August 16, 2022 by President Biden. Further details available here: https://aspe.hhs.gov/sites/default/files/documents/bd5568fa0e8a59c2225b2e0b93d5ae5b/aspe-insulin-affordibility-datapoint.pdf
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-01-02 19:50:05 UTC (1704225005852) |
2024-01-02 22:40:57 UTC (1704235257997) |
CURRENTLY_RATED_HELPFUL | 2024-01-03 09:49:49 UTC (1704275389997) |
CURRENTLY_RATED_HELPFUL | 2024-01-02 22:40:57 UTC (1704235257997) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-01-02 18:31:04 -0600 | Rating Details | |
2024-01-02 18:29:47 -0600 | Rating Details | |
2024-01-02 18:08:45 -0600 | Rating Details | |
2024-01-02 18:08:12 -0600 | Rating Details | |
2024-01-02 17:45:50 -0600 | Rating Details | |
2024-01-02 17:43:31 -0600 | Rating Details | |
2024-01-02 17:43:11 -0600 | Rating Details | |
2024-01-02 17:32:40 -0600 | Rating Details | |
2024-01-02 17:21:26 -0600 | Rating Details | |
2024-01-02 17:20:14 -0600 | Rating Details | |
2024-01-02 16:59:40 -0600 | Rating Details | |
2024-01-02 16:38:06 -0600 | Rating Details | |
2024-01-02 16:34:39 -0600 | Rating Details | |
2024-01-02 16:31:40 -0600 | Rating Details | |
2024-01-02 16:24:36 -0600 | Rating Details | |
2024-01-02 16:14:54 -0600 | Rating Details | |
2024-01-02 16:03:59 -0600 | Rating Details | |
2024-01-02 16:03:49 -0600 | Rating Details | |
2024-01-02 16:01:06 -0600 | Rating Details | |
2024-01-02 15:50:15 -0600 | Rating Details | |
2024-01-02 15:47:31 -0600 | Rating Details | |
2024-01-02 15:34:54 -0600 | Rating Details | |
2024-01-02 15:29:40 -0600 | Rating Details | |
2024-01-02 15:27:20 -0600 | Rating Details | |
2024-01-02 15:25:10 -0600 | Rating Details | |
2024-01-02 15:19:14 -0600 | Rating Details | |
2024-01-02 15:14:33 -0600 | Rating Details | |
2024-01-02 15:10:13 -0600 | Rating Details | |
2024-01-02 15:07:43 -0600 | Rating Details | |
2024-01-02 15:05:34 -0600 | Rating Details | |
2024-01-02 14:55:17 -0600 | Rating Details | |
2024-01-02 14:52:31 -0600 | Rating Details | |
2024-01-02 14:50:20 -0600 | Rating Details | |
2024-01-02 14:49:33 -0600 | Rating Details | |
2024-01-02 14:48:17 -0600 | Rating Details | |
2024-01-02 14:44:00 -0600 | Rating Details | |
2024-01-02 14:43:19 -0600 | Rating Details | |
2024-01-02 14:36:34 -0600 | Rating Details | |
2024-01-02 14:34:00 -0600 | Rating Details | |
2024-01-02 14:33:57 -0600 | Rating Details | |
2024-01-02 14:32:23 -0600 | Rating Details | |
2024-01-02 14:27:00 -0600 | Rating Details | |
2024-01-02 14:18:10 -0600 | Rating Details | |
2024-01-02 14:15:31 -0600 | Rating Details | |
2024-01-02 14:14:53 -0600 | Rating Details | |
2024-01-02 14:14:51 -0600 | Rating Details | |
2024-01-02 14:13:29 -0600 | Rating Details | |
2024-01-02 14:10:42 -0600 | Rating Details | |
2024-01-02 14:05:16 -0600 | Rating Details | |
2024-01-02 13:56:21 -0600 | Rating Details | |
2024-01-02 13:55:42 -0600 | Rating Details | |
2024-01-02 13:54:31 -0600 | Rating Details | |
2024-01-02 13:54:07 -0600 | Rating Details | |
2024-01-03 16:13:08 -0600 | Rating Details | |
2024-01-03 15:30:25 -0600 | Rating Details | |
2024-01-03 15:27:47 -0600 | Rating Details | |
2024-01-03 14:57:06 -0600 | Rating Details | |
2024-01-03 11:14:35 -0600 | Rating Details | |
2024-01-03 11:04:44 -0600 | Rating Details | |
2024-01-03 10:39:38 -0600 | Rating Details | |
2024-01-03 09:42:02 -0600 | Rating Details | |
2024-01-03 09:29:22 -0600 | Rating Details | |
2024-01-03 09:02:55 -0600 | Rating Details | |
2024-01-03 08:59:52 -0600 | Rating Details | |
2024-01-03 08:49:29 -0600 | Rating Details | |
2024-01-03 08:38:17 -0600 | Rating Details | |
2024-01-03 08:09:36 -0600 | Rating Details | |
2024-01-03 07:55:05 -0600 | Rating Details | |
2024-01-03 07:17:22 -0600 | Rating Details | |
2024-01-03 06:58:22 -0600 | Rating Details | |
2024-01-03 06:50:33 -0600 | Rating Details | |
2024-01-03 06:24:19 -0600 | Rating Details | |
2024-01-03 05:52:29 -0600 | Rating Details | |
2024-01-03 05:50:45 -0600 | Rating Details | |
2024-01-03 05:31:56 -0600 | Rating Details | |
2024-01-03 04:46:47 -0600 | Rating Details | |
2024-01-03 02:49:14 -0600 | Rating Details | |
2024-01-03 02:47:18 -0600 | Rating Details | |
2024-01-03 02:03:12 -0600 | Rating Details | |
2024-01-03 00:06:00 -0600 | Rating Details | |
2024-01-03 00:05:10 -0600 | Rating Details | |
2024-01-03 00:00:24 -0600 | Rating Details | |
2024-01-02 23:54:04 -0600 | Rating Details | |
2024-01-02 23:37:31 -0600 | Rating Details | |
2024-01-02 23:07:40 -0600 | Rating Details | |
2024-01-02 22:57:23 -0600 | Rating Details | |
2024-01-02 22:40:46 -0600 | Rating Details | |
2024-01-02 21:25:46 -0600 | Rating Details | |
2024-01-02 21:22:31 -0600 | Rating Details | |
2024-01-02 20:48:34 -0600 | Rating Details | |
2024-01-02 20:44:11 -0600 | Rating Details | |
2024-01-02 20:20:56 -0600 | Rating Details | |
2024-01-02 19:52:49 -0600 | Rating Details | |
2024-01-02 19:49:09 -0600 | Rating Details | |
2024-01-02 19:31:13 -0600 | Rating Details | |
2024-01-02 19:08:01 -0600 | Rating Details | |
2024-01-02 18:43:45 -0600 | Rating Details | |
2024-01-04 16:35:38 -0600 | Rating Details | |
2024-01-04 16:10:45 -0600 | Rating Details | |
2024-01-04 10:09:57 -0600 | Rating Details | |
2024-01-04 04:31:40 -0600 | Rating Details | |
2024-01-04 01:34:14 -0600 | Rating Details | |
2024-01-03 22:55:41 -0600 | Rating Details | |
2024-01-03 22:30:43 -0600 | Rating Details | |
2024-01-03 20:17:31 -0600 | Rating Details | |
2024-01-05 10:54:34 -0600 | Rating Details | |
2024-01-05 14:48:56 -0600 | Rating Details | |
2024-01-11 07:12:00 -0600 | Rating Details | |
2024-01-04 15:59:59 -0600 | Rating Details |